CUAMC
TERN

China Universal Asset Management Company’s Terns Pharmaceuticals TERN Stock Holding History

China Universal Asset Management Company’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,869
Closed -$995K – 541
2026
Q1 		$995K Buy
18,869
+3,991
+27% +$164K 0.08% 191
2025
Q4 		$601K Sell
14,878
-461
-3% -$10.7K 0.05% 241
2025
Q3 		$115K Sell
15,339
-2,202
-13% -$14.1K 0.01% 376
2025
Q2 		$65.4K Buy
17,541
+504
+3% +$1.57K 0.01% 398
2025
Q1 		$47K Sell
17,037
-973
-5% -$3.97K ﹤0.01% 423
2024
Q4 		$99.8K Buy
18,010
+4,475
+33% +$30.3K 0.01% 390
2024
Q3 		$113K Buy
13,535
+5,935
+78% +$48.8K 0.01% 347
2024
Q2 		$51.8K Sell
7,600
-4,289
-36% -$26K 0.01% 352
2024
Q1 		$78K Buy
11,889
+4,742
+66% +$31K 0.01% 391
2023
Q4 		$46.4K Buy
7,147
+5,587
+358% +$29.5K 0.01% 376
2023
Q3 		$7.85K Buy
1,560
+817
+110% +$5.18K ﹤0.01% 360
2023
Q2 		$6.5K Buy
743
+72
+11% +$839 ﹤0.01% 343
2023
Q1 		$7.95K Buy
671
+288
+75% +$2.75K ﹤0.01% 323
2022
Q4 		$3.9K Buy
383
+30
+8% +$200 ﹤0.01% 323
2022
Q3 		$2K Buy
+353
New +$1.31K ﹤0.01% 360

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

China Universal Asset Management Company's TERN Position: Q2 2026 in Review

China Universal Asset Management Company sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 18,869 shares — an estimated $995K sold.

China Universal Asset Management Company first reported a position in TERN in Q3 2022 and held it in 15 quarters. The position peaked at $995K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • China Universal Asset Management Company reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • China Universal Asset Management Company sold 18,869 Terns Pharmaceuticals shares in Q2 2026, an estimated $995K.
  • China Universal Asset Management Company first reported a position in Terns Pharmaceuticals in Q3 2022 and held it in 15 quarters.
  • China Universal Asset Management Company's Terns Pharmaceuticals position peaked at $995K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.